TABLE 2.

Occurrence of infectious and allograft rejection episodes in relation to onset of EBV syndrome

Case no.	Timing of episodes of allograft rejectiona		Infectious episodes
	Before diagnosis of EBV (days)	After diagnosis of EBV (days)	Before diagnosis of EBV	After diagnosis of EBV
1	None	+17	Blood cultured staphylococci and CMV	Candida pharyngitis, CMV pneumonitis, staphylococcal septicemia
2	−35, −13	+18	None	Escherichia coli (abdominal wound)
3	None	+5, +38, +111	Herpes simplex (lip)	None
4	−10	+133, +169, +307	CMV viremia	Urine-cultured CMV, E coli, and S fecalis
5	None	None	CMV hepatitis, pneumocytis infection	S viridans pharyngitis
6	−20	+ 11, +80	Herpes simplex, Streptococcus viridans pharyngitis	Cholangitis, bile-cultured coagulase negative staphylococci, S fecalis
7	−33	+8	CMV uveitis	Bile-cultured citrobacter, S fecium, candida
8	−2	+13	Urine-cultured Candida stellatoidea	Groin wound infection by S fecalis, coagulase-negative staphylococci
9	−3, −37	None	None	None
10	None	+25	None	Urine cultured E coli, enterococci, candida. Bronchoalveolar lavage–cultured candida

^a−, number of days rejection preceded the onset of a clinical syndrome; +, number of days that rejection occurred after the diagnosis of viral syndrome.